Skip to main content

#161582

Anti-CD109 monoclonal antibody [KU43.13A]

Cat. #161582

Anti-CD109 monoclonal antibody [KU43.13A]

Cat. #: 161582

Sub-type: Primary antibody

Availability: 3-4 weeks

Target: CD109

Class: Monoclonal

Application: IHC, IF, IP, WB, ELISA, FACS

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Helmout Modjtahedi

Institute: Kingston University

Primary Citation: Arias-Pinilla et al. 2018. Oncotarget. 9(28): 19994–20007. PMID: 29731998

Tool Details
Target Details
Applications
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CD109 monoclonal antibody [KU43.13A]
  • Cancer: Pancreatic cancer
  • Cancers detailed: Pancreatic cancer
  • Research fields: Cancer
  • Clone: KU43.13A
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Molecular weight: 170 KDa
  • Reactivity: Human
  • Host: Mouse
  • Disease: Cancer
  • Application: IHC, IF, IP, WB, ELISA, FACS
  • Description: KU43.13A mAb detects CD109 antigen with high level of expression in some of the human pancreatic cell lines (e.g. BxPC-3, PANC-1, FA-6 and MIA PaCa-2)
  • Immunogen: BxPC-3 cells
  • Isotype: IgG2a

Target Details

  • Target: CD109
  • Molecular weight: 170 KDa
  • Target background: CD109 is a glycosylphosphatidylinositol (GPI)-anchored glycoprotein that localizes to the surface of platelets, activated T-cells, and endothelial cells. It is highly expressed in cancers of various organs including the pancreas, lung, esophagus, uterine cervix, penis, and gallbladder, but hardly detectable in their normal tissues.

Applications

  • Application: IHC, IF, IP, WB, ELISA, FACS

Handling

  • Shipping conditions: Dry ice

Related Tools

  • Related tools: KU44.22B monoclonal antibody

References

  • Arias-Pinilla et al. 2018. Oncotarget. 9(28): 19994–20007. PMID: 29731998
  • Arias-Pinilla et al. 2020. Sci Rep. 10(1):537. PMID: 31953437

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.